Turner Syndrome and Hepatic Adenomas: A Case Report.

Susan Ahern, Sindy H Wei

Abstract readCase Reports

In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Susan AhernEndocrinology, Diabetes and Metabolism, University of California, Los Angeles, USA.

Sindy H WeiAbdominal Imaging, University of California, Los Angeles, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This case report describes large hepatic adenomas in a 35-year-old woman with Turner syndrome (TS) who had long-standing oral estradiol exposure and metabolic syndrome. Patients with TS may be at increased risk of hepatic adenomas when compared to the general population. Future research papers should seek to understand the true incidence of hepatic adenomas in TS, whether we should implement routine imaging screening for hepatic adenomas without abnormal liver function labs, and whether transdermal estradiol is safe after a diagnosis of hepatic adenomas.

Indexed as

hepatic adenomalarge hepatic adenomas on oral combined contraceptivemetabolic syndrome in turner syndrometransaminase elevation in turner syndrometurner syndrome

Identifiers

PMID41356875

DOI10.7759/cureus.96137

PMCPMC12681431

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.